News

Researchers are pursuing several strategies for drug discovery and repurposing using the latest advances in artificial intelligence integrated into our battle-tested discovery platform. COVID-19 is more severe and lethal in the elderly, low-dose rapamycin may be a potential strategy to protect this population.

A Monash University-led study has shown that an anti-parasitic drug already available around the world can kill the virus within 48 hours in cell culture.

A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective therapeutic strategy against COVID-19 in infected patients who also have multiple myeloma and other blood cancers.

A sponge found in Manado Bay, Indonesia, synthesizes a molecule called manzamine A, which has been shown to stop the growth of cervical cancer cells. The study explored the anti-growth and cancer cell-killing effects of manzamine A in different cervical cancer cell lines.

An antibody recovered from a survivor of the SARS epidemic in the early 2000s has revealed a potential vulnerability of the new coronavirus at the root of COVID-19, according to a study from scientists at Scripps Research.

South Australian researchers are testing a vaccine candidate against the SARS-CoV-2 coronavirus responsible for the COVID-19 pandemic.

OCF is assisting its customers to get involved in “Folding@home” in the fight against COVID-19.

Some researchers are saying that it's time for regulators, scientists, and the public to "revisit drugs that were once used but fell out of use because of political machinations, especially the war on drugs."

Houston Methodist researchers have designed a platform where a diabetes drug is chemically linked to fatty acids and then packaged in a nanoparticle resistant to the stomach’s gastric acids.

University of Pittsburgh School of Medicine scientists announced a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. When tested in mice, the vaccine, delivered through a fingertip-sized patch, produces antibodies specific to SARS-CoV-2 at quantities thought to be sufficient for neutralizing the virus.